Home  /  Resource Library  /  Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation

Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation

Study investigate outcomes of patients with MCL treated with CAR-T Brexucabtagene autoleucel in Asia.